Skip to main content
. 2023 Jan 5;13(1):163. doi: 10.3390/life13010163

Table 1.

Description of the included studies.

Author (Year) Study Design Diagnosis Groups Characterization (Intervention: n, Age, % Females) Intervention Control BDNF: Sample/Analysis Kit BDNF Results Pain Outcome Pain Results
Dall’Agnol et al., 2014 [24] RCT CMPS rTMS: n = 11, 45.83 (9.63), 100%
Sham: n = 12, 44.83 (14.09), 100%
rTMS.
Left motor cortex (M1).
Trains: 16 series of 10 sec.pulse/high-frequency of 10 Hz biphasic magnetic stimulator 26 s rest.
1600 pulses per session. 10 sessions.
Sham
Identical experience but without the impulses
Serum/ELISA Not expose intra-group changes
rTMS Increased BDNF vs. Sham
VAS Higher pain score was correlated negatively with serum BDNF level [r-squared = 0.89, Beta= −0.15, SE = 0.008, (CI) 95%
−0.17 to −0.13].
Botelho et al., 2018 [25] RCT CMPS EIMS n = 12 48.36 (10.97) 100%
Sham n = 12 46.00 (13.55) 100%
EIMS
Paraspinal region related to the nerve roots
(the splenius capitis and semispinalis capitis).
20-min at at 2 Hz. 10 sessions
Sham
The same device but the output jack plug was broken
Serum/ELISA Intra-group: EIMS increased BDNF
EIMS Increased BDNF vs. Sham
VAS Increase in serum BDNF induced by the EIMS was correlated negatively with pain at the end of follow-up (Beta: 0.67 t = 2.24 p = 0,02 (CI) 95% = 0.07 to 1.26)
Dos Santos et al., 2018 [26] RCT FM tDCS n = 20, 49.15 (8.43) 100%
Sham n = 20 50.05 (11.19) 100%
tDCS with a cognitive training task.
Anode over the left DLPFC, cathode at right supraorbital
region. 2 mA for 20 min.
The cognitive training: online app of a Dual N-Back task.
8 consecutive days.
Sham
The stimulator was turned off after a ramp-up of 30 s of stimulation
Serum/ELISA Does not expose the results VAS Does not expose the results
Da Graca-Tarragó et al., 2019 [27] RCT Knee OA a-EIMS/A-TDCS n = 15 66 (9.08) 100%
A-tDCS/s-EIMS n = 15 64.4 (9.82) 100%
S-TDCS/a-EIMS n = 15 64.40 (6.02) 100%
s-tDCS/S-EIMS n = 15 63.87 (7.07) 100%
a-tDCS
Anodal in the contralateral primary motor cortex (M1), cathode in the contralateral supraorbital region. 2 mA, rumps 30 s, 0.057 mA/cm2, electrodes 35 cm 2.5 s, 30 min.
a-EIMS
Needles (40 mm × 0.25 mm + constant current 2 Hz, intensity adjusted to tolerability, location 12 L1-S2, vast medial, rectur femoris, vast lateral, anterior tibialis and pes anserine bursae, 5 s, 30 min.
Sham transcranial direct current stimulation (s-tDCS)
The stimulator was turned off after a ramp-up of 30 s of stimulation

Sham intramuscular electrical stimulation (s-EIMS)
electrodes were placed on the sites where the needles were placed. No electrical stimulation passed to the patient
Serum/ELISA Not expose intra-group changes
No difference between groups neither at baseline nor at the treatment end
VAS, PPT Serum BDNF levels at baseline were correlated negatively with the PPT at the end of the treatment
All groups showed decreased pain scores over time
The aTDCS/aEIMS produced higher reduction compared with all three groups
Medeiros et al., 2016 [28] RCT CMPS a-rTMS/a-DIMST n = 11 49.18 (11.63) 100%
a-rTMS/s-DIMST n = 12 45.83 (9.63) 100%
s-rTMS/a-DIMST n = 12 47.25 (11.00) 100%
s-rTMS/s-DIMST n = 11 46.73 (13.09) 100%
a-TMS
Coil over the left primary motor cortex.
600 pulses at 10 Hz frequency 80% resting motor threshold (rMT) intensity. 10 sessions for 20 min each one.
a-DIMST
Needles (40 mm × 0.25 mm). Nerve roots C2-C3, C3-C4, and C4-C5.
Distance from the spinous process line: 1.5 cm).
10 sessions for 20 min using a frequency of 2 Hz.
Sham repetitive transcranial magnetic stimulation (s-TMS)
A sham coil was used
Sham deep intramuscular stimulation therapy (s-DIMST)
Used an electroacupuncture device where the electrical connection between the stimulator and the patient was broken
at the output jack plug of the stimulator
Serum/ELISA No changes in BDNF levels VAS All groups presented lower level of Pain VAS than
sham-rTMS sham-DIMST.
RCT: randomized controlled trial; rTMS: Repetitive transcranial magnetic stimulation; EIMS: Intramuscular electrical stimulation; DIMST: deep intramuscular stimulation therapy; tDCS: transcranidirect current stimulation; ELISA: enzyme-linked immunosorbent assay; BDNF: Brain derived neurotrophic factor; VAS: Visual Analogic Scale; KOOS: Knee injury and Osteoarthritis Outcome Score; PPT: Pressure pain threshold; FM: Fibromyalgia; CMPS: Chronic Myofascial Pain Syndrome: OA: Osteoarthritis; DLPFC: Dorso lateral prefrontal cortex.
Autor (year) Study design Diagnosis Groups characterization (Intervention: n, age, % females) Intervention Control BDNF: sample/analysis kit BDNF Results Pain outcome Pain results
Liu et al., 2019 [22] RCT Knee OA Exercise:
(a) Tai Chi n = 35 58.61 (7.62)
(b) Baduanjin n = 35 59.66 (7.36)
(c) Stationary cycling n = 35 61.26 (7.53)
Control n = 35 56.88 (6.51)
Exercise; Tai Chi, Baduanjin and Stationary cycling.
1 h 5/w for 12 w
Control: Basic health education 1 h, 1/w for 12 w Serum/ELISA Not expose intra-group changes
No difference between groups
KOOS pain Taichi, Baduanjin and cycling decreased pain (increased KOOS pain score) vs. control
Jablochkoba et al., 2019 [21] RCT FM Resistance exercisen = 41 100%
Relaxation therapy n = 34 100%
Resistance exercise
Supervised: 10-min warm-up + 50 min. started with 40% MVC, developed up to 70–80%. 2/w for 15 w
Relaxation therapy: 25-min supervised mental exercises. 2/week. Plasma/(ECLIA) Intra-group: No changes in BDNF levels in FM (either in the exercise or in the relaxion group)
No differences between groups (exercise vs. relaxion group)
VAS No significant multivariate relationships were found between the changes in BDNF and pain in FM
RCT: randomized controlled trial; ECLIA: electrochemiluminescence assay panel; BDNF: Brain derived neurotrophic factor; VAS: Visual Analogic Scale; KOOS: Knee injury and Osteoarthritis Outcome Score; FM: Fibromyalgia; OA: Osteoarthritis.